Spasmolytic polypeptide-expressing metaplasia: the hidden linchpin in gastric carcinogenesis beyond the Correa cascade

化生 肠化生 转分化 癌变 医学 炎症 癌症研究 幽门螺杆菌 萎缩性胃炎 生物 病理 癌症 电池类型 胃粘膜 粘液 细胞 表观遗传学 慢性胃炎 细胞生长 促炎细胞因子 胃炎 生长因子 腺癌 免疫学 非典型增生 癌前状态 细胞分化
作者
Tai Zhang,Lanshuo Hu,Beihua Zhang,Xudong Tang
出处
期刊:International Journal of Surgery [Wolters Kluwer]
卷期号:112 (3): 7951-8035 被引量:6
标识
DOI:10.1097/js9.0000000000004273
摘要

Gastric cancer remains a leading cause of cancer-related mortality worldwide, necessitating improved understanding of its precancerous stages. While Professor Correa's cascade-which describes progression from atrophy to intestinal metaplasia to cancer-has long been held as the paradigm for gastric carcinogenesis, emerging evidence suggests a more complex pathway. The identification of compound glands containing basal proliferative intestinalized spasmolytic polypeptide-expressing metaplasia (SPEM) cells with luminal intestinal elements provides compelling morphological evidence for SPEM-driven carcinogenesis pathways. This review positions SPEM as an earlier and potentially more critical intervention point than previously recognized intestinal metaplasia. SPEM is characterized by trefoil factor 2-expressing cells that replace normal gastric lineages following parietal cell loss, representing a distinct metaplastic entity arising through either chief cell transdifferentiation or stem cell differentiation. Importantly, this metaplastic change occurs earlier in the carcinogenic sequence than traditional models suggest. SPEM exhibits remarkable biological duality determined by inflammatory context: canonical SPEM arising in acute injury serves beneficial reparative functions through mucus secretion, growth factor production, and reactive oxygen species defense, whereas proliferative intestinalized SPEM developing under chronic inflammation represents a high-risk precancerous state characterized by sustained proliferation, mixed gastric-intestinal lineage features, and autonomous cell cycle programming. Under chronic inflammatory conditions driven primarily by Helicobacter pylori infection, canonical SPEM may advance through a defined progression pathway: canonical SPEM → proliferative intestinalized SPEM → incomplete intestinal metaplasia. Molecularly, this transition is characterized by fundamental changes in cellular behavior and gene expression. Proliferative intestinalized SPEM, which constitutes a key component of incomplete intestinal metaplastic glands, exhibits sustained Ki-67-positive proliferation, progressive expression of intestinal transcripts including cystic fibrosis transmembrane conductance regulator (CFTR), glutathione peroxidase 2 (GPX2), deleted in malignant brain tumors 1 (DMBT1), polymeric immunoglobulin receptor (PIGR), and villin 1 (VIL1), and autonomous cell cycle programming that persists even after removal of the initial inflammatory stimulus. This progression is orchestrated largely by the interleukin-33/interleukin-13 signaling axis through type 2 immune responses, a self-perpetuating inflammatory microenvironment that continuously drives metaplastic transformation toward increasingly proliferative and intestinalized phenotypes. A critical distinction exists between canonical SPEM (protective, transient, fully reversible following Helicobacter pylori eradication) and proliferative intestinalized SPEM (pathological, persistent, therapeutically irreversible). Canonical SPEM demonstrates complete reversibility following Helicobacter pylori eradication, defining a valuable therapeutic window for intervention. In contrast, proliferative intestinalized SPEM-which manifests histologically as incomplete intestinal metaplasia-represents an irreversible "histological point of no return" with persistent proliferative dysfunction and autonomous cell cycle programming. Recent molecular characterization has enabled differentiation between these reversible canonical SPEM and high-risk proliferative forms, with clinical validation showing that proliferative intestinalized SPEM persists despite bacterial eradication. The significance of SPEM in gastric carcinogenesis is underscored by its near-universal presence in resected gastric cancers (approximately 90%) and its temporal precedence to intestinal metaplasia. These findings strongly support SPEM's role as a critical precancerous lesion that may have been underappreciated in traditional models. This review synthesizes current understanding of SPEM's pathogenesis, molecular mechanisms, and clinical implications. Furthermore, it proposes integration of SPEM assessment into gastric cancer risk stratification protocols to enable earlier intervention strategies that interrupt carcinogenesis at its most vulnerable and potentially reversible stage.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
乐乐的应助被hehehe采纳,获得10
刚刚
刚刚
Huang完成签到,获得积分10
1秒前
1秒前
香蕉觅云的应助被zmh采纳,获得10
1秒前
2秒前
ghshen的应助被希音采纳,获得10
2秒前
2秒前
3秒前
weiwei完成签到,获得积分10
3秒前
传奇3的应助被ty12390采纳,获得10
3秒前
传奇3的应助被微风采纳,获得10
4秒前
董子瑜发布了新的文献求助10
4秒前
kobe发布了新的文献求助10
4秒前
白白发布了新的文献求助10
4秒前
xier完成签到,获得积分10
4秒前
5秒前
hiittjw完成签到,获得积分10
5秒前
5秒前
阿金发布了新的文献求助10
6秒前
清城完成签到,获得积分10
6秒前
KD357完成签到,获得积分10
7秒前
今后的应助被老实的硬币采纳,获得10
7秒前
共享精神的应助被Ava采纳,获得10
7秒前
H2发布了新的文献求助10
8秒前
123456完成签到,获得积分10
9秒前
9秒前
RXE关注了科研通微信公众号
10秒前
科研通AI6.2的应助被fortuna采纳,获得10
10秒前
ww完成签到,获得积分10
10秒前
Meng发布了新的文献求助10
10秒前
11秒前
12秒前
SHY完成签到,获得积分20
12秒前
椰汁味完成签到,获得积分10
13秒前
哭泣煎蛋完成签到 ,获得积分10
13秒前
刘柳发布了新的文献求助10
13秒前
脑洞疼的应助被xh采纳,获得10
13秒前
烟花的应助被tph采纳,获得10
13秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161554
求助须知:如何正确求助?哪些是违规求助? 9556174
关于积分的说明 21732775
捐赠科研通 7751537
什么是DOI,文献DOI怎么找? 3427556
关于科研通互助平台的介绍 2552588
邀请新用户注册赠送积分活动 2472023